Deep rTMS in Central Neuropathic Pain Syndromes "DRTMS"


Phase N/A Results N/A

Summary of Purpose

Pain affects up to 30% of the general population. In particular, neuropathic pain (NeP) is caused by lesion or desease affecting peripheral or central somatosensory pathways and affects 7% of the adult population. Despite the availability of evidence based pharmacological and surgical treatment for NeP, about 50% of patients remais symptomatic despite best medical treatment. Some neuropathic pain syndromes are...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 8 May 2017.

1 Mar 2011 27 Aug 2013 1 Dec 2013 1 Aug 2015 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment